News Wire

The FDA has announced two new voluntary programs—the Quality Metrics Feedback Program and the Quality Metrics Site Visit Program—in response to stakeholder requests for continued information and feedback on quality metrics, and to provide methods for industry to engage and inform the FDA’s use of them in the future.

Pfizer Inc. plans to increase research and development spending for the remainder of the year in an ambitious plan to accelerate the delivery of potential blockbuster treatments to market.

Almirall announced that both phase 3 studies of KX2-391 for actinic keratosis (AK), met the primary endpoint of complete clearance of AK lesions at Day 57 within the face or scalp treatment areas, each study achieving statistical significance (P P

CMS recently unveiled a plan that would affect about 40% of payments made to physicians by Medicare.

Pfizer officials say they expect that perhaps 30 drugs in its pipeline will be approved through 2022.

One of the byproducts of the many hospital mergers that have occurred in recent years is that it makes it easier to transfer patients, the Star Tribune of Minnesota reports.

“We spend the majority of our money and resources addressing people once they’re sick,” Cigna’s CEO David Cordani told Business Insider (BI) in an interview last week.

Under the ACA, CMS started to not just take the word of nursing homes regarding how well they are staffed, and instead started looking at payrolls to find the answer. That answer was pretty shocking, Kaiser Health News (KHN) reports.

Some heavy-hitting health care organizations think that the prior authorization process needs improvement, saying that it “can be burdensome for all involved—health care providers, health plans, and patients. Yet, there is wide variation in medical practice and adherence to evidence-based treatment.”

Centene CEO Michael Niedorff told analysts on a call about second quarter earnings yesterday that “we’re not out there buying all the practices we can and all the clinics that we can.” That’s in response to Centene’s acquisition of Community Medical Group in Florida, which owns 15 health centers in the Miami-Dade County area, 

“I’ve fallen, and I can’t get up!” was first used in commercials for a company called LifeLine in the late 1980s and often as a punchline by comedians, but the deterioration associated with old age is no laughing matter for those going through it. That device depended on the patient contacting emergency rescue personnel.

Last week, HHS Secretary Alex Azar requested that Food and Drug Administration Commissioner Scott Gottlieb create a working group to find how to safely import drugs from abroad in cases when their U.S.-marketed equivalents undergo dramatic price increases.

The birth control device Essure is taking its final bow. The United States was the last market in which Essure, manufactured by Bayer AG, had been sold. As the Wall Street Journal reports, the company decided to stop selling the product because of declining sales. “The U.S.

The small biotech company Alzheon hasn’t given up on its big push to get approval for tramiprosate, its beta-amyloid-targeting drug that it says can be used for patients genetically disposed to Alzheimer’s.